UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
March 23, 2021 12:00 P.M.
Form:
S-4
CIK:
0001321834
Company Name:
Akers Biosciences, Inc.
File Number:
333-252181